FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Morgan

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Robert J Morgan; Warren Chow; Paul Frankel; David R Gandara; Agustin Garcia; Heinz-Josef Lenz; Lucille Leong; James H Doroshow
Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study.
Joseph Chao; Vincent Chung; Angela Davies; Igor Espinoza-Delgado; David R Gandara; Barbara J Gitlitz; Charles Kunos; Derick H Lau; Heinz-Josef Lenz; Dean Lim; Jeff Longmate; Mark McNamara; Robert J Morgan; Edward M Newman; Suresh S Ramalingam; Stephen Shibata; Ronald G Stoller; Timothy W Synold; Chandra P Belani; Yun Yen
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.
Robert J Morgan; Timothy W Synold; Adam N Mamelak; Dean Lim; Zaid Al-Kadhimi; Przemyslaw Twardowski; Lucille Leong; Warren Chow; Kim Margolin; Stephen Shibata; George Somlo; Yun Yen; Paul Frankel; James Doroshow
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Morgan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Robert J Morgan; Warren Chow; Paul Frankel; David R Gandara; Agustin Garcia; Heinz-Josef Lenz; Lucille Leong; James H Doroshow
Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study.
Investigational new drugs 2012;30(2):723-8.
2012: Joseph Chao; Vincent Chung; Angela Davies; Igor Espinoza-Delgado; David R Gandara; Barbara J Gitlitz; Charles Kunos; Derick H Lau; Heinz-Josef Lenz; Dean Lim; Jeff Longmate; Mark McNamara; Robert J Morgan; Edward M Newman; Suresh S Ramalingam; Stephen Shibata; Ronald G Stoller; Timothy W Synold; Chandra P Belani; Yun Yen
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.
Cancer chemotherapy and pharmacology 2012;69(3):835-43.
2010: Robert J Morgan; Timothy W Synold; Adam N Mamelak; Dean Lim; Zaid Al-Kadhimi; Przemyslaw Twardowski; Lucille Leong; Warren Chow; Kim Margolin; Stephen Shibata; George Somlo; Yun Yen; Paul Frankel; James Doroshow
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.
Cancer chemotherapy and pharmacology 2010;66(5):927-33.
2010: Mihaela Cristea; Ernest Han; Lennie Salmon; Robert J Morgan
Practical considerations in ovarian cancer chemotherapy.
Therapeutic advances in medical oncology 2010;2(3):175-87.
2010: Thehang Luu; Warren Chow; Dean Lim; Marianna Koczywas; Paul Frankel; Mihaela Cristea; Kim Margolin; James H Doroshow; George Somlo; Shikha Gaur; Yun Yen; Robert J Morgan
Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors.
Anticancer research 2010;30(1):167-74.
2009: Stephen I Shibata; James Doroshow; Paul Frankel; Timothy W Synold; Yun Yen; David R Gandara; Heinz-Josef Lenz; Warren A Chow; Lucille A Leong; Dean Lim; Kim Margolin; Robert J Morgan; George Somlo; Edward M Newman
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.
Cancer chemotherapy and pharmacology 2009;64(6):1149-55.
2008: Thehang H Luu; Robert J Morgan; Lucille Leong; Dean Lim; Mark McNamara; Jana Portnow; Paul Frankel; David D Smith; James Doroshow; Carol Wong; Ana Aparicio; David R Gandara; George Somlo
A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):7138-42.
2008: Yun Yen; Dean W Lim; Vincent Chung; Robert J Morgan; Lucille A Leong; Stephen I Shibata; Lawrence D Wagman; Stephen D Wagman; Howard Marx; Peiguo G Chu; Jeff Longmate; Heinz-Josef Lenz; Ramesh K Ramanathan; Chandra P Belani; David R Gandara
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial.
American journal of clinical oncology 2008;31(4):317-22.
2007: Thomas Lowe; Robert J Morgan
Intraperitoneal chemotherapy of ovarian cancer.
Women's health (London, England) 2007;3(4):433-40.
2007: Robert J Morgan; Timothy W Synold; David R Gandara; Franco Muggia; Sidney Scudder; E Reed; Kim Margolin; James Raschko; Lucille Leong; Stephen Shibata; Merry Tetef; Steven Vasilev; Kathryn F McGonigle; Jeff Longmate; Yun Yen; Warren Chow; George Somlo; Mary Carroll; James Doroshow
Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(2):373-8.
2007: Robert J Morgan; Timothy W Synold; Bixin Xi; Dean Lim; Stephen Shibata; Kim Margolin; Roderich E Schwarz; Lucille Leong; George Somlo; Przemyslaw Twardowski; Yun Yen; Warren Chow; Merry Tetef; Paul Lin; Benjamin Paz; Mariana Koczywas; Lawrence D Wagman; David Chu; Paul Frankel; Susan Stalter; James Doroshow
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1232-7.
2006: Kathryn F McGonigle; D D Smith; H F Marx; Robert J Morgan; Steven Vasilev; S Roy; P T Wong; J F Simpson; S P Wilczynski
Uterine effects of tamoxifen: a prospective study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(2):814-20.
2005: Kim Margolin; James Doroshow; Paul Frankel; Warren Chow; Lucille A Leong; Dean Lim; Mark McNamara; Robert J Morgan; Stephen Shibata; George Somlo; Przemyslaw Twardowski; Yun Yen; Neil Kogut; Jeffrey Schriber; Joseph Alvarnas; Susan Stalter
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(11):903-11.
2005: Dean Lim; Robert J Morgan; Steven Akman; Kim Margolin; Brian I Carr; Lucille Leong; Oluwole Odujinrin; James Doroshow
Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy.
Investigational new drugs 2005;23(3):235-9.
2004: Robert J Morgan; Timothy W Synold; David R Gandara; Franco Muggia; Sidney Scudder; Eddie Reed; Kim Margolin; James Raschko; Lucille Leong; Stephen Shibata; Merry Tetef; Steven Vasilev; Kathryn F McGonigle; Jeff Longmate; Yun Yen; Warren Chow; George Somlo; Mary Carroll; James Doroshow
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
Cancer chemotherapy and pharmacology 2004;54(4):283-9.
2004: Warren A Chow; Timothy W Synold; Merry Tetef; Jeff Longmate; Paul Frankel; Joyce Lawrence; Zaid Al-Khadimi; Lucille Leong; Dean Lim; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; George Somlo; Przemyslaw Twardowski; Yun Yen; James Doroshow
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
Cancer chemotherapy and pharmacology 2004;54(3):241-8.
2004: Stephen Shibata; Richard D Pezner; David Chu; James Doroshow; Warren A Chow; Lucille A Leong; Kim Margolin; Mark McNamara; Robert J Morgan; James Raschko; George Somlo; Merry Tetef; Yun Yen; Timothy W Synold; Lawrence D Wagman; Nayana L Vora; Mary Carroll; S Lin; Jeff Longmate
A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2004;30(6):650-7.
2003: Robert J Morgan; James Doroshow; Timothy W Synold; Dean Lim; Stephen Shibata; Kim Margolin; Roderich Schwarz; Lucille Leong; George Somlo; Przemyslaw Twardowski; Yun Yen; Warren Chow; Paul Lin; Benjamin Paz; David Chu; Paul Frankel; Susan Stalter
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5896-901.
2003: Robert J Morgan; Edward M Newman; Lawrence C Sowers; Kevin Scanlon; Jonathan Harrison; Steven Akman; Lucille Leong; Kim Margolin; Joyce C Niland; James Raschko; George Somlo; Mary Carroll; Warren Chow; Merry Tetef; Victor Hamasaki; Yun Yen; James Doroshow
Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies.
Cancer chemotherapy and pharmacology 2003;51(6):459-64.
2001: Robert J Morgan; James Doroshow; Lucille Leong; Jeffrey Schriber; Stephen Shibata; Stephen Forman; Victor Hamasaki; Kim Margolin; George Somlo; Joseph Alvarnas; Mark McNamara; Jeff Longmate; James Raschko; Warren Chow; Steven Vasilev; Kathryn F McGonigle; Yun Yen
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
Bone marrow transplantation 2001;28(9):859-63.
2001: George Somlo; James Doroshow; Timothy W Synold; Jeff Longmate; D Reardon; Warren Chow; Stephen J Forman; Lucille A Leong; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; Merry Tetef; Yun Yen; Neil Kogut; Jeffrey Schriber; Joseph Alvarnas
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.
British journal of cancer 2001;84(12):1591-8.
2001: Robert J Morgan; Timothy W Synold; B I Carr; James Doroshow; E P Womack; Stephen Shibata; George Somlo; James Raschko; Lucille Leong; Mark McNamara; Warren Chow; Merry Tetef; Kim Margolin; Steven Akman; Jeff Longmate
Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy.
Cancer chemotherapy and pharmacology 2001;47(4):327-32.
2000: Robert J Morgan; P Braly; Lucille Leong; Stephen Shibata; Kim Margolin; George Somlo; Mark McNamara; Jeff Longmate; S Schinke; James Raschko; S Nagasawa; Neil Kogut; L Najera; D Johnson; James Doroshow
Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
Gynecologic oncology 2000;77(3):433-8.
2000: James Raschko; Timothy W Synold; Warren Chow; PH Coluzzi; Victor Hamasaki; Lucille A Leong; Kim Margolin; Robert J Morgan; Stephen Shibata; George Somlo; Merry Tetef; Yun Yen; A ter Veer; James Doroshow
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A.
Cancer chemotherapy and pharmacology 2000;46(5):403-10.
2000: Merry Tetef; Kim Margolin; James Doroshow; Steven Akman; Lucille A Leong; Robert J Morgan; James Raschko; Neal E Slatkin; George Somlo; Jeff Longmate; M I Carroll; Edward M Newman
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.
Cancer chemotherapy and pharmacology 2000;46(1):19-26.
1999: Robert J Morgan; P Braly; G Cecchi; Lucille Leong; Stephen Shibata; Kim Margolin; George Somlo; Mark McNamara; Jeff Longmate; S Schinke; James Raschko; S Nagasawa; Neil Kogut; Pablo Parker; Anthony Stein; J Cho; E Smith; PH Coluzzi; L Najera; D Johnson; E Womack; James Doroshow
Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
Gynecologic oncology 1999;75(3):419-26.
1999: Merry Tetef; Lucille Leong; Chul Ahn; Steven Akman; Warren Chow; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; George Somlo; James Doroshow
Cisplatin and infusional cytosine arabinoside for the treatment of colorectal adenocarcinoma: a phase II trial.
Cancer investigation 1999;17(2):114-7.
1998: Robert J Morgan; Edward M Newman; James Doroshow; Kathryn F McGonigle; Kim Margolin; James Raschko; Warren Chow; George Somlo; Lucille Leong; Merry Tetef; Stephen Shibata; Victor Hamasaki; Mary Carroll; Steven Vasilev; Steven Akman; PH Coluzzi; Lawrence D Wagman; Jeff Longmate; Benjamin Paz; Yun Yen; Robert R Klevecz
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
Cancer research 1998;58(13):2793-800.
1997: Robert J Morgan; James Doroshow; K Venkataraman; K Chang; James Raschko; George Somlo; Lucille Leong; Merry Tetef; Stephen Shibata; Victor Hamasaki; Kim Margolin; Stephen Forman; Steven Akman; PH Coluzzi; Chul Ahn; L Weiss; U Gadgil; J Harrison
High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2337-45.
1997: Edward M Newman; Mary Carroll; Steven Akman; Warren Chow; PH Coluzzi; Victor Hamasaki; Lucille A Leong; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; George Somlo; Merry Tetef; Yun Yen; Chul Ahn; James Doroshow
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 1997;39(3):254-8.
1995: Robert J Morgan; Kim Margolin; James Raschko; Steven Akman; Lucille Leong; George Somlo; K Scanlon; Chul Ahn; M Carroll; James Doroshow
Phase I trial of carboplatin and infusional cyclosporin in advanced malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(9):2238-46.
1995: Robert J Morgan; James Speyer; James Doroshow; Kim Margolin; James Raschko; Joan Sorich; Steven Akman; Lucille Leong; George Somlo; Steven Vasilev
Modulation of 5-fluorouracil with high-dose leucovorin calcium: activity in ovarian cancer and correlation with CA-125 levels.
Gynecologic oncology 1995;58(1):79-85.
1995: George Somlo; James Doroshow; A Lev-Ran; D C Ahn; L Hwang; James Raschko; Stephen J Forman; Kim Margolin; Robert J Morgan; L A Leong
Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1231-7.
1995: Merry Tetef; Kim Margolin; Chul Ahn; Steven Akman; Warren Chow; Lucille Leong; Robert J Morgan; James Raschko; George Somlo; James Doroshow
Mitomycin C and menadione for the treatment of lung cancer: a phase II trial.
Investigational new drugs 1995;13(2):157-62.
1995: Merry Tetef; Kim Margolin; Chul Ahn; Steven Akman; Warren Chow; PH Coluzzi; Lucille Leong; Robert J Morgan; James Raschko; Stephen Shibata
Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial.
Journal of cancer research and clinical oncology 1995;121(2):103-6.
1995: R R Klevecz; L P Brown; Robert J Morgan; Mary Carroll
Circadian optimization of treatment time using DNA replication-dependent cell-cycle-specific halogenated pyrimidines.
The Journal of infusional chemotherapy 1995;5(1):15-9.
1995: Kim Margolin; Steven Akman; L A Leong; Robert J Morgan; George Somlo; James Raschko; Chul Ahn; James Doroshow
Phase I study of mitomycin C and menadione in advanced solid tumors.
Cancer chemotherapy and pharmacology 1995;36(4):293-8.
1995: Merry Tetef; James Doroshow; Steven Akman; PH Coluzzi; Lucille Leong; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; George Somlo
5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial.
Cancer investigation 1995;13(5):460-3.
1994: Kim Margolin; S Green; C Kent Osborne; James Doroshow; Steven Akman; L A Leong; Robert J Morgan; James Raschko; George Somlo; L Hutchins
Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancer.
American journal of clinical oncology 1994;17(2):175-80.
1994: George Somlo; James Doroshow; Stephen J Forman; L A Leong; Kim Margolin; Robert J Morgan; James Raschko; Steven Akman; Chul Ahn; S Nagasawa
High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.
Cancer 1994;73(6):1678-85.
1994: James Raschko; Steven Akman; L A Leong; Kim Margolin; Robert J Morgan; E Newman; George Somlo; Chul Ahn; James Doroshow
Phase I study of 5-day continuous infusion fluorodeoxyuridine and high-dose folinic acid with oral hydroxyurea.
Cancer chemotherapy and pharmacology 1994;35(2):161-4.
1994: George Somlo; James Doroshow; Stephen J Forman; L A Leong; Kim Margolin; Robert J Morgan; James Raschko; Steven Akman; Chul Ahn; Irena Sniecinski
High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
Cancer 1994;73(1):125-34.
1992: Kim Margolin; James Doroshow; Steven Akman; L A Leong; Robert J Morgan; George Somlo; James Raschko; C Pereira; L Yonemoto; C Ahn
Phase II trial of cisplatin and alpha-interferon in advanced malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1574-8.
1992: Kim Margolin; James Doroshow; Steven Akman; L A Leong; Robert J Morgan; James Raschko; George Somlo; C Blevins
Effective initial therapy of advanced breast cancer with fluorouracil and high-dose, continuous infusion calcium leucovorin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1278-83.
1992: Edward M Newman; Steven Akman; J S Harrison; L A Leong; Kim Margolin; Robert J Morgan; James Raschko; George Somlo; C W Ahn; James Doroshow
Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer.
Cancer research 1992;52(9):2408-12.
1992: Kim Margolin; James Doroshow; Steven Akman; L A Leong; Robert J Morgan; James Raschko; George Somlo; B Mills; D Goldberg; Irena Sniecinski
Phase I trial of interleukin-2 plus gamma-interferon.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;11(1):50-5.